The Missouri House Emerging Issues Committee has unanimously approved the Kratom Consumer Protection Act (HB 1037), 13 to 0.
Kratom.
The bill, if passed into law, would implement strict guidelines on the sale, labeling, and contents of kratom products to ensure consumer safety.
Kratom, derived from the Mitragyna speciosa plant native to Southeast Asia, is widely used for its stimulant and opioid-like effects. Many consumers take kratom for pain relief, anxiety management, or as an alternative to opioids, though its legal status has been an issue of debate in numerous states this year. Without federal regulation, kratom products vary in potency and purity, leading some states to enact their own oversight measures.
Under HB 1037, kratom products must be properly labeled, listing the amounts of mitragynine and 7-hydroxymitragynine, the two primary alkaloids responsible for its effects. The bill prohibits sales to individuals under 21 and bans kratom that is adulterated or contaminated with dangerous substances. It also outlaws synthetic kratom derivatives and products that contain more than 2% 7-hydroxymitragynine, which is considered a highly potent compound.
Violators of the law could face penalties, including fines and Class D misdemeanor charges for selling unsafe or mislabeled kratom. Additionally, consumers who suffer harm due to violations could seek legal damages.
The bill now heads to the full House for further debate, with strong bipartisan support suggesting it has a solid chance of advancing through the legislative process.
